SCOTT MATHIS: Open Payments
NPI 1356535322 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 61 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,082 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $230 |
| PFIZER INC. | 10 | $153 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| ABBVIE INC. | 4 | $89 |
| Antares Pharma, Inc. | 5 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
| Dexcom, Inc. | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Indivior Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $60 |
Products named: CAPLYTA, NURTEC ODT, TRELEGY ELLIPTA, XYOSTED, XIFAXAN, Dexcom G6 Transmitter, REXULTI, LINZESS.
Industry payments across GA — which companies pay providers there.
